HEATHER KURIGER: Open Payments
NPI 1609181882 · BRANDON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,133 in 108 payments from 18 companies in 2025. Trend: 2023 $2,006 · 2024 $1,983 · 2025 $2,133
Food & beverage: $2,133
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $372 |
| Corcept Therapeutics | 12 | $323 |
| ABBVIE INC. | 17 | $281 |
| PFIZER INC. | 11 | $207 |
| GlaxoSmithKline, LLC. | 10 | $181 |
| AstraZeneca Pharmaceuticals LP | 7 | $135 |
| Lilly USA, LLC | 6 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $88 |
| Amgen Inc. | 6 | $87 |
| Esperion Therapeutics, Inc. | 4 | $77 |
Products named: Korlym, Ozempic, TRELEGY ELLIPTA, FARXIGA, PREVNAR 20, VRAYLAR, UBRELVY, MOUNJARO.
Industry payments across MS — which companies pay providers there.
